http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
사례보고 : 간절제술 후 원발병소인 간내 재발 없이 간외전이를 일으킨 간상피모양혈관내피종 1예
정승원 ( Soung Won Jeong ),우현영 ( Hyun Young Woo ),유찬란 ( Chan Ran You ),허원행 ( Won Hang Huh ),배시현 ( Si Hyun Bae ),최종영 ( Jong Young Choi ),윤승규 ( Seung Kew Yoon ),정찬권 ( Chan Kwon Jung ),정은선 ( Eun Sun Jung ) 대한간학회 2008 Clinical and Molecular Hepatology(대한간학회지) Vol.14 No.4
간상피모양혈관내피종은 혈관에서 기원하는 종양으로 간에서 발생하는 가장 드문 육종 중의 하나로서 저등도에서 중등도의 악성도를 가지고 있다. 아직까지 원인은 알려져 있지 않으며 예후 또한 예측하기 어렵다. 발생빈도가 낮고, 불균일한 특성, 다양한 임상경과 등으로 현재까지 정해져 있는 치료지침은 없다. 저자들은 64세 여자 환자에서 우엽에 발생한 간상피모양혈관내피종을 간절제술을 시행하고 22개월 후에, 원발병소인 간내 재발은 없이 골, 흉막, 복강 등으로 간외전이를 보인 사례를 경험하였기에 문헌고찰과 함께 보고하는 바이다. Epithelioid hemangioendothelioma is a neoplasm of vascular origin with a low-to-intermediate malignant potential and is one of the rare sarcomas arising from the liver. Its etiology is unknown and its clinical outcome is unpredictable. There is no generally accepted therapeutic strategy because of its rarity and the variable natural course between hemangioma and angiosarcoma. We report a case of a 64-year old woman who underwent hepatic resection due to epithelioid hemangioendothelioma in the right lobe that progressed to extrahepatic metastases of the bone, pleura, and peritoneum 22 months later. However, after resection there was no primary hepatic recurrence. (Korean J Hepatol 2008;14:525-531)
검진센터에서 헬리코박터 필로리 혈청 IgG 항체 검사가 필요한가?
권정현 ( Jung Hyun Kwon ),최명규 ( Myung Gyu Choi ),허원행 ( Won Hang Huh ),서정필 ( Jung Pil Suh ),남관우 ( Kwan Woo Nam ),장재혁 ( Jae Hyuck Chang ),박재명 ( Jae Myung Park ),조유경 ( Yu Kyung Cho ),이인석 ( In Seok Lee ),김상우 대한내과학회 2008 대한내과학회지 Vol.75 No.3
Background/Aims: The serum Helicobacter pylori IgG antibody test has been widely used by primary care physicians for over two decades. We assessed its usefulness as a screening strategy for organic gastrointestinal disease in routine check-up. Methods: We retrospectively reviewed the medical records of 10,080 subjects who received a routine check up at the Kangnam St. Mary`s Hospital from January 2004 to April 2005. All subjects underwent the H. pylori IgG antibody test and upper gastrointestinal endoscopy or a barium contrast study. Results: The overall seropositive rate for H. pylori detection was 61.0% (6,150/10,180). The 13C-urea breath test (UBT) was performed in 340 subjects. The H. pylori antibody test showed 55% accuracy in comparison to the standard 13C-UBT. The number of patients with peptic ulcer in the seropositive group was 475 (7.7%) compared to only 168 patients (4.3%) in the seronegative group (p<0.001). Stomach cancer was observed in eight (0.1%) and two (0.1%) patients in the seropositive and seronegative groups, respectively. The positive and negative likelihood ratios for the H. pylori IgG antibody test for peptic ulcer were 1.22 and 0.66, respectively, compared to 1.31 and 0.26 for stomach cancer. Conclusions: In view of its low accuracy and likelihood ratios, we do not recommend the H. pylori antibody test as a diagnostic tool for H. pylori infection or as a screening strategy for organic gastrointestinal disease during routine check-ups. (Korean J Med 75:300-306, 2008)